| 71.37 0.6 (0.85%) | 09-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 85 | 1-year : | 87.12 |
| Resists | First : | 72.77 | Second : | 74.58 |
| Pivot price | 71.49 |
|||
| Supports | First : | 69.84 | Second : | 58.11 |
| MAs | MA(5) : | 70.69 |
MA(20) : | 72.03 |
| MA(100) : | 66.79 |
MA(250) : | 64.43 |
|
| MACD | MACD : | 0 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 25.9 |
D(3) : | 20.2 |
| RSI | RSI(14): 50.9 |
|||
| 52-week | High : | 74.58 | Low : | 55.9 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IYH ] has closed above bottom band by 44.5%. Bollinger Bands are 0.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 71.53 - 71.82 | 71.82 - 72.1 |
| Low: | 70.14 - 70.46 | 70.46 - 70.77 |
| Close: | 70.74 - 71.25 | 71.25 - 71.73 |
The iShares U.S. Healthcare ETF is designed to mirror the investment performance of a benchmark index that consists of stocks from American companies within the healthcare industry.
Tue, 15 Sep 2026
iShares U.S. Healthcare ETF declares quarterly distribution of $0.1908 - TradingView
Wed, 09 Sep 2026
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? - The Motley Fool
Tue, 08 Sep 2026
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026? - The Motley Fool
Tue, 08 Sep 2026
Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits - The Motley Fool
Wed, 02 Sep 2026
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? - Yahoo Finance
Wed, 02 Sep 2026
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|